Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mirum Pharmaceuticals (MIRM) Operating Expenses: 2019-2024

Historic Operating Expenses for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Dec 2024 value amounting to $424.5 million.

  • Mirum Pharmaceuticals' Operating Expenses rose 26.53% to $130.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $513.6 million, marking a year-over-year increase of 27.44%. This contributed to the annual value of $424.5 million for FY2024, which is 43.64% up from last year.
  • According to the latest figures from FY2024, Mirum Pharmaceuticals' Operating Expenses is $424.5 million, which was up 43.64% from $295.5 million recorded in FY2023.
  • Over the past 5 years, Mirum Pharmaceuticals' Operating Expenses peaked at $424.5 million during FY2024, and registered a low of $104.3 million during FY2020.
  • Over the past 3 years, Mirum Pharmaceuticals' median Operating Expenses value was $295.5 million (recorded in 2023), while the average stood at $309.4 million.
  • Data for Mirum Pharmaceuticals' Operating Expenses shows a peak YoY skyrocketed of 90.52% (in 2020) over the last 5 years.
  • Over the past 5 years, Mirum Pharmaceuticals' Operating Expenses (Yearly) stood at $104.3 million in 2020, then soared by 84.62% to $192.6 million in 2021, then rose by 8.17% to $208.3 million in 2022, then skyrocketed by 41.89% to $295.5 million in 2023, then skyrocketed by 43.64% to $424.5 million in 2024.